Specialty therapeutics organization develops a patented formulation for chronic wound treatment, utilizing urea to disaggregate necrotic material and enhance wound healing with a physiological buffer in a hydrocolloidal base. The product aims to provide effective treatment regardless of wound conditions and limitations common to enzyme-based therapies.